Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study

BACKGROUND: To date, real-world evidence on persistence to anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies (mAbs) or onabotulinumtoxinA have excluded eptinezumab. This retrospective cohort study was performed to compare treatment persistency among patients with migraine on ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Charleston, Larry, Talon, Brian, Sullivan, Christine, Anderson, Carlton, Kymes, Steven, Regnier, Stephane A., Soni-Brahmbhatt, Seema, Nahas, Stephanie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394944/
https://www.ncbi.nlm.nih.gov/pubmed/37532991
http://dx.doi.org/10.1186/s10194-023-01636-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394944/
https://www.ncbi.nlm.nih.gov/pubmed/37532991
http://dx.doi.org/10.1186/s10194-023-01636-8

Ejemplares similares